Skip to main content

Detail

Matthias Paireder
Matthias Paireder, MD

Department of Surgery (Division of General Surgery)
Position: Consultant

ORCID: 0000-0001-7119-8454
matthias.paireder@meduniwien.ac.at

Further Information

Keywords

Barrett Esophagus; Esophageal Neoplasms; Oncology; Upper Gastrointestinal Tract

Research group(s)

  • Upper Gastrointestinal Research and Service

Grants

  • Fellowship of Surgical Oncology (2014)
    Source of Funding: Austrian Society of Surgical Oncology, Ingrid Shaker-Nessmann Cancer Research Association
    Principal Investigator

Selected publications

  1. Paireder, M. et al., 2017. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. European Journal of Surgical Oncology (EJSO), 43(2), pp.478-484. Available at: http://dx.doi.org/10.1016/j.ejso.2016.11.015.
  2. Tamandl, D. et al., 2015. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. European Radiology, 26(5), pp.1359-1367. Available at: http://dx.doi.org/10.1007/s00330-015-3963-1.
  3. Kollmann, D. et al., 2017. Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma. Annals of Surgical Oncology. Available at: http://dx.doi.org/10.1245/s10434-017-5858-7.
  4. Jomrich, G. et al., 2014. Stromal expression of carbonic anhydrase IX in esophageal cancer. Clinical and Translational Oncology, 16(11), pp.966-972. Available at: http://dx.doi.org/10.1007/s12094-014-1180-z.